Fund of the week: An oasis of calm

Even during the stormy years of the eurozone crisis, this European fund still made its investors money.

Calm investors have made big profits in Europe in recent years, in spite of the eurozone crisis. If you had invested £1,000 in the Jupiter European Opportunities investment trust (LSE: JEO) five years ago, it would now be worth around £3,600.

The fund is the top-performing European investment trust over the period, thrashing its benchmark (the MSCI Europe index rose 93%).

"If you think the recovery in Europe has only begun, this is a good fund in which to participate," says Citywire's Gavin Lumsden. The trust is run by Alexander Darwall, "a stand-out performer" in recent years, according to Lumsden. "His due diligence process is very strong he looks to identify companies with compelling growth traits."

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

The trust's performance was especially strong in 2009/2010, when quality growth' companies were in fashion. Over the last year, performance has been more pedestrian roughly in line with its benchmark as many investors have switched to more cyclical stocks, including banks.

672-FOTW

On the downside, the fund trades on a small premium of 1.4%. So its market value is slightly higher than the value of its underlying assets. The premium may put off some investors, but Darwall's track record means it should be a good way to benefit from long-term growth in Europe.

Swipe to scroll horizontally
Wirecard7.98%
Novo Nordisk7.37%
Reed Elsevier7.27%
Experian6.97%
Provident Financial6.57%
Syngenta6.16%
Novozymes6.06%
Croda International5.15%
Intertek5.15%
Fresenius5.05%